Kihara M, Ikeuchi M, Kobayashi Y, Nagao Y, Hashizume M, Moritoki H
Faculty of Pharmaceutical Sciences, University of Tokushima, Japan.
Drug Des Discov. 1994 Apr;11(3):175-83.
2-Methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline-4-ol(PI-OH) (2a) and its derivatives form a new class of compounds possessing norepinephrine (NE) potentiating activity. As a new series of compounds, the isomeric 4-(4-hydroxyphenyl)- and 4-(3-hydroxyphenyl)-2-methyl-1,2,3,4- tetrahydroisoquinolin-4-ols (3a and 3b), and 4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolin-4-ol (3c) were prepared and their NE potentiating activities were evaluated. The 4-(4-hydroxyphenyl) analogue (3a) had only moderate activity and the 4-(3-hydroxyphenyl) analogue (3b) possessed a slightly higher activity than PI-OH. The 4-(3,4-dihydroxyphenyl) analogue (3c) was the most active compound and the pD2 value was 7.71 +/- 0.06 (activity ratio; 26.9 fold) at a concentration of 3 x 10(-6) M. These results indicate the importance of dihydroxyphenylethanolamine moiety of 3c for the inhibition of NE uptake.
2-甲基-4-苯基-1,2,3,4-四氢异喹啉-4-醇(PI-OH)(2a)及其衍生物构成了一类具有去甲肾上腺素(NE)增强活性的新型化合物。作为一系列新的化合物,制备了异构体4-(4-羟基苯基)-和4-(3-羟基苯基)-2-甲基-1,2,3,4-四氢异喹啉-4-醇(3a和3b)以及4-(3,4-二羟基苯基)-1,2,3,4-四氢异喹啉-4-醇(3c),并评估了它们的NE增强活性。4-(4-羟基苯基)类似物(3a)仅具有中等活性,4-(3-羟基苯基)类似物(3b)的活性略高于PI-OH。4-(3,4-二羟基苯基)类似物(3c)是活性最高的化合物,在浓度为3×10⁻⁶ M时,pD2值为7.71±0.06(活性比;26.9倍)。这些结果表明3c的二羟基苯乙醇胺部分对抑制NE摄取的重要性。